Phase I study of autologous dendritic cell tumor vaccine in patients with non-small cell lung cancer

Building on dendritic cell subsets to improve cancer vaccines

Increased prevalence of regulatory T cells in the tumor microenvironment and its correlation with TNM stage of hepatocellular carcinoma

Toll-like receptor expression and function in human dendritic cell subsets: implications for dendritic cell-based anti-cancer immunotherapy

Fine-tuning immune surveillance by fever-range thermal stress

Diverse immune mechanisms may contribute to the survival benefit seen in cancer patients receiving hyperthermia

New perspectives in cancer virotherapy: bringing the immune system into play

The evolving role of dendritic cells in cancer therapy

Dendritic Cells-based Vaccine and Immune Monitoring for Hepatocellular Carcinoma

Dendritic cells pulsed with an anti-idiotype antibody mimicking Her-2/neu induced protective antitumor immunity in two lines of Her-2/neu transgenic mice